Picterus
Trondheim
About Picterus
Picterus is an app under development designed to diagnose Jaundice in newborns. Untreated jaundice in newborns is responsible for more than 100,000 deaths each year. More than three-quarters of these deaths occur in the poorest regions of the world, in Sub-Saharan Africa and South Asia. Cheap treatment is partially available, but the screening devices in use today cost around 7,000 dollars, making them practically unavailable in low-resource settings. In addition, due to the global trend of shorter hospital stays after birth, there is now a large unmet need for tools to follow-up jaundice in families' homes. With jaundice now being the number one reason for readmissions to hospitals after birth.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.6M
- Funding stage: Seed
- Last round: Grant (Jun 2023)
- Website: picterus.com
- Phone: +47 95305601
Industries & Categories
Apps, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/picterus-69994 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.